CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sanara Medtech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sanara Medtech Inc
1200 Summit Avenue, Suite 414
Phone: (817) 529-2300p:817 529-2300 FORT WORTH, TX  76102  United States Ticker: SMTISMTI
Business Summary
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies
2834 Pharmaceutical preparations
8011 Offices and clinics of doctors of medicine
6794 Patent owners and lessors

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer Ronald T.Nixon 68 5/12/2024 3/1/2019
Chief Financial Officer Michael D.McNeil 59 4/11/2018 4/11/2018
Chief Operating Officer Jacob A.Waldrop 42 4/15/2024 4/15/2024
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Wound Care Innovations, LLC 6400 North Andrews Avenue Fort Lauderdale FL United States
Scendia Biologics LLC 111 W Jefferson St Orlando FL United States
Precision Healing, Inc. 275 Washington Street Newton MA United States

Business Names
Business Name
Cellerate, LLC
Pixalere Healthcare USA, LLC
Precision Healing, Inc.
13 additional Business Names available in full report.

General Information
Number of Employees: 107 (As of 12/31/2023)
Outstanding Shares: 8,741,161 (As of 11/8/2024)
Shareholders: 283
Stock Exchange: NASD
Federal Tax Id: 592220004


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024